Sinopharm Holding Dongguan Co., Ltd. announced that it will receive CNY 55,000,000 on April 19, 2017. The transaction will include participation from China National Accord Medicines Corporation Ltd. (SZSE:000028) to maintain its 100% stake in the company after the transaction. The registered capital of the company will increase from CNY 18,000,000 to CNY 73,000,000. The transaction was approved at the 22nd meeting of the 7th directorate of investor and does not need its shareholders’ approval. The company reported total assets of CNY 289,890,000, net assets of CNY 33,780,000, and revenue of CNY 687,110,000 for the year ended December 31, 2016.